home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Revolution Medicines Announces Pricing of Upsized $260.9 Million Public Offering of Common Stock
Revolution Medicines Announces Pricing of Upsized $260.9 Million Public Offering of Common Stock
Post navigation
Previous Post
Previous
Circle Pharma appoints Constantine Kreatsoulas, PhD as its Vice President, Research Informatics and Computational Chemistry
Next Post
Next
Turning Point Therapeutics to Participate in Guggenheim Healthcare Talks 2021 Oncology Days